Home・Listă Acțiuni・Medpace Holdings Inc

Medpace Holdings Inc

Deschisă

SectorSănătate

579.14 -1.03

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

565.71

Maxim

592.34

Indicatori cheie
By Trading Economics
Venit	-2.5M 121M
Vânzări	727K 707M
P/E Medie Sector	35.334 64.641
EPS	4.25
Marjă de profit	17.158
Angajați	6,500
EBITDA	-21M 134M

Recomandări
By TipRanks
Recomandări	Neutru
Prognoză pe 12 luni	-0.81% downside

Dividende
By Acuity
Următoarele câștiguri	21 oct. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	1.4B 16B
Deschiderea anterioară	580.17
Închiderea anterioară	579.14

Sentimentul știrilor

By Acuity

50%

158 / 340 Clasament în Healthcare

Medpace Holdings Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

29 iul. 2026, 18:44 UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

28 iul. 2026, 23:11 UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

27 iul. 2026, 16:56 UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

24 iul. 2026, 18:26 UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

22 iul. 2026, 23:22 UTC

Social Media

News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21 iul. 2026, 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Comparație

Modificare preț

Medpace Holdings Inc Așteptări

Obiectiv de preț

By TipRanks

-0.81% jos

Prognoză pe 12 luni

Medie 580.2 USD -0.81%

Maxim 692 USD

Minim 450 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMedpace Holdings Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

11 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 11 analiști care au acordat evaluări ale acțiunilor Medpace Holdings Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

158 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.